MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. [electronic resource]
- World journal of gastroenterology Jun 2019
- 2752-2762 p. digital
Publication Type: Journal Article
2219-2840
10.3748/wjg.v25.i22.2752 doi
ATP Binding Cassette Transporter, Subfamily B--genetics Apoptosis--drug effects Carcinoma, Hepatocellular--drug therapy Cell Survival--drug effects Disease Progression Down-Regulation Doxorubicin--pharmacology Drug Resistance, Neoplasm--genetics Gene Expression Regulation, Neoplastic Genetic Vectors Hep G2 Cells Humans Liver Neoplasms--drug therapy MicroRNAs--genetics Proto-Oncogene Proteins--genetics Receptor Protein-Tyrosine Kinases--genetics Transfection Tumor Suppressor Protein p53--genetics Up-Regulation Axl Receptor Tyrosine Kinase